Presentations -
-
慢性骨髄性白血病における新たな無治療寛解維持予測因子としてのミトコンドリアDNAコピー数の検討
鈴木未央, 飯島和香奈, 市川大樹, 山崎理絵, 櫻井政寿, 片山圭亮, 岡本真一郎, 服部豊, 松下麻衣子
第86回日本血液学会学術集会 (京都) ,
2024.10,Poster presentation
-
松下麻衣子,栗田昂希,藤浪太晴,須藤豊,市川大樹,服部豊
第21回日本免疫治療学会学術集会,
2024.05,Poster presentation
-
Epigenetic factor CDYL2 attenuates lenalidomide snsitivity in multiple myeloma
Daiju Ichikawa, Yuna Kamioka, Maiko Mastushita, Yutaka Hattori
第48回日本骨髄腫学会学術集会 (東京, 日本) ,
2023.05,Poster presentation
-
Investigating the safety and efficacy of natural products that induce immunogenic cell death in multiple myeloma
藤浪太晴, 栗田昴希, 松下麻衣子, 市川大樹, 須藤豊, 服部豊
第48回日本骨髄腫学会学術集会 (東京, 日本) ,
2023.05,Oral presentation (general)
-
Epigenetic factor CDYL2 is associated with lenalidomide-resistance in multiple myeloma
市川 大樹, 松下 麻衣子, 服部 豊
日本薬学会 第143年会 (北海道札幌市) ,
2023.03,Poster presentation, 日本薬学会
-
多発性骨髄腫に対して免疫原性細胞死を誘導するコマロビキノン誘導体の開発
栗田昂希、松下麻衣子、田村快斗、市川大樹、須藤豊、岩崎源司、服部豊
第84回日本血液学会学術集会,
2022.10,Poster presentation
-
ドラッグリポジショニングにより見出されたアンブロキソールのオートファジー阻害を介した抗骨髄腫効果
杉山裕夢、市川大樹、松下麻衣子、服部豊、他
第84回日本血液学会学術集会,
2022.10,Oral presentation (general)
-
多発性骨髄腫に対して免疫原性細胞死を誘導するコマロビキノン誘導体の開発
栗田昂希、臼井凜、唐﨑翼、杉山裕夢、市川大樹、松下麻衣子、服部豊
第22回PHシンポジウム,
2022.06,Oral presentation (general)
-
Effect of Multiple Myeloma Therapeutics on Autophagy Pathway
Ryo Kaneko, Daiju Ichikawa, Maiko Matsushita, Yutaka Hattori.
第80回日本癌学会学術総会,
2021.10,Poster presentation
-
The study of signaling pathways contributing to immunogenic cell death in multiple myeloma
Yuta Shimizu, Daiju Ichikawa, Maiko Matsushita, Yutaka Hattori
第46回日本骨髄腫学会学術集会,
2021.05,Poster presentation
-
A novel candidate for immunological target in treatment of multiple myeloma.
Maiko Matsushita, Saku Saito, Kanae Mori, Shinya Yokoe, Daiju Ichikawa, Yutaka Hattori
An AACR Special Conference on Tumor Immunology and Immunotherapy (Boston Marriott Copley Place,Boston, U.S.A. ) ,
2019.11 -
Dedifferentiation by reprogramming genes augments drug resistance and clonal growth in myeloma cells
Hiroki Tsuji, Takumi Futo, Koichi Samata, Tomofumi Yamamoto, Daiju Ichikawa, Maiko Matsushita, Yutaka Hattori
The 81th Annual Meeting of the Japanese Society of Hematology,
2019.10,Poster presentation
-
Diverse molecular mechanisms of lenalidomide resistance in multiple myeloma cells
Takumi Futo, Ryo Uozaki, Takashi Yamaguchi, Tomofumi Yamamoto， Hiroki Tsuji, Koichi Samata, Daiju Ichikawa，Maiko Matsushita, Yutaka Hattori
The 81th Annual Meeting of the Japanese Society of Hematology,
2019.10,Oral presentation (general)
-
komaroviquinoneという天然物由来の新規化合物がin vivoにおいて抗MM活性を示す
佐俣光一、岡山幹夫、藤森宏太、山元智史、市川大樹、松下麻衣子、須藤豊、岩崎源司、山田健人、服部豊
第78回日本癌学会学術総会,
2019.09,国立京都国際会館 京都
-
天然物由来成分komaroviquinone及びその誘導体群はin vivoにおいて抗骨髄腫活性を示す
佐俣光一、岡山幹夫、藤森宏太、西山沙織、辻宏樹、不藤拓海、市川大樹、松下麻衣子、岩崎源司、須藤豊、山田健人、平尾磨樹、国枝尚子、長田眞、服部豊
日本薬学会生物系薬学部会第20回Pharmaco-Hematologyシンポジウム (日本薬学会長井記念館 東京) ,
2019.06 -
Characteristics of Cytotoxic T Cells against Myeloma Cells for Adoptive Immunotherapy.
Saku Saito, Maiko Matsushita, Kanae Mori, Shinya Yokoe, Daiju Ichikawa, Yutaka Hattori
(鳥羽国際ホテル,三重県鳥羽市) ,
2019.05,第10回日本血液学会（JSH）国際シンポジウム
-
Elucidation of the IMiDs-Resistant Mechanism and Development of the Overcoming Drugs Inducing CRBN Independent G2/M Cell Cycle Arrest in Myeloma Cells.
Ryo Uozaki, Shuji Aida, Takasi Yamagughi, Tomofumi Yamamoto, BPharm, Sho Kashiwazaki, Hiroshi Yanagawa, Daiju Ichikawa, Maiko Matsushita and Yutaka Hattori.
60th AMERICAN SOCIETY of HEMATOLOGY Annual Meeting and Exposition. (San Diego CA.) ,
2018.12,Poster presentation
-
Immunomodulatory Effects of Proteasome Inhibitors in Multiple Myeloma.
Sho Kashiwazaki, Satoshi Kamiko, Ryo Uozaki, Tomofumi Yamamoto, Daiju Ichikawa, Yutaka Hattori, Maiko Matsushita, Maki Hirao, Hisako Kunieda and Kohei Yamazaki
60th AMERICAN SOCIETY of HEMATOLOGY Annual Meeting and Exposition. (San Diego CA.) ,
2018.12,Poster presentation
-
新規天然化合物コマロビキノン化合物の抗骨髄腫効果および構造展開
ICHIKAWA Daiju
第80回日本血液学会学術集会 (大阪国際会議場 大阪市) ,
2018.10,Oral presentation (general)
-
プロテアソーム阻害薬の免疫原性細胞死による免疫調節機能
ICHIKAWA Daiju
第80回日本血液学会学術集会 (大阪国際会議場 大阪市) ,
2018.10 -
多発性骨髄腫のIMIDs抵抗性メカニズムの解明
ICHIKAWA Daiju
第77回日本癌学会学術集会 (大阪国際会議場 大阪市) ,
2018.09,Poster presentation
-
Cereblon-independent anti-myeloma pathway of TC11, a novel compound of immunomodulatory drugs
Daiju Ichikawa, Shuji Aida, Nahoko Hashimoto, Wakana Murota, Ryo Uozaki, Mikio Okayama, Kota Fujimori, Yuko Yonemura, Noriko Tabata, Hiroshi Yanagawa, Maiko Matsushita, Yutaka Hattori
第79回日本血液学会,
2017.10,Oral presentation (general)
-
PEG(E)-TC11, a novel PEG phthalimide derivative, inhibited MM cell growth CRBN independent manner.
ICHIKAWA Daiju
第42回日本骨髄腫学会学術集会,
2017.05,Poster presentation
-
PEG(E)-TC11, a novel polyethylene glycol-linked phthalimide derivative, inhibited high-risk MM cell growth in vivo and in vitro via cell cycle G2/M arrest in a CRBN-independent manner.
Shuji Aida, Daiju Ichikawa, Kazuki Iida, Masashi Hozumi, Misa Nakamura, Ryo Uozaki, Nahoko Hashimoto, Mikio Okayama, Yuko Yonemura, Noriko Tabata, Taketo Yamada, Maiko Matsushita, Takeshi Sugai, Hiroshi Yanagawa, Yutaka Hattori
American association for cancer research annual meeting 2017,
2017.04,Poster presentation
-
Komaroviquinone-Derivatives, Revealed Anti-Tumor Effect on High-Risk Multiple Myeloma Cells In Vitro as Well as In Vivo
Mariko Sato, Kota Fujimori, Shotaro Kitabatake, Mikio Okayama, Daiju Ichikawa, Yutaka Suto, Genji Iwasaki, Fumiyuki Kiuchi, Takashi Yamaguchi, Arimi Ueda, Shuji Aida, Hitomi Nakayama, Maiko Matsushita, and Yutaka Hattori
ASH, 58th Annual Meeting & Exposition,
2016.12,Poster presentation
-
Structural optimization and anti-tumor activities of komaroviquinone to high-risk myeloma
ICHIKAWA Daiju
第78回日本血液学会学術集会,
2016.10,Oral presentation (general)
-
ハイリスク多発性骨髄腫に対する新規komaroviquinone誘導体による克服薬の開発
ICHIKAWA Daiju
第41回日本骨髄腫学会学術集会,
2016.05,Poster presentation
-
Drug Design for Overcoming High-Risk Myeloma and Identification of Novel Binding Proteins to Immune-Modulatory Drugs
ICHIKAWA DaijuMasashi Hozumi, Daiju Ichikawa, Maiko Matsushita, Eriko Kamiyama, Hiroshi Yanagawa, Noriko Tabata, Shotaro Kitabatake, Arimi Ueda, Takashi Yamaguchi, Mariko Sato, and Yutaka Hattori.
57th Annual Meeting and Exposition (Orlando, FL) ,
2015.12,Poster presentation
-
Monitoring of immunity against leukemia stem cell in CML patients after cessation of TKI.
Matsushita M, Koji Ozawa, Kanchi S, Uchiumi A, Suzuki T, Ichikawa D, Matsuski E, Sakurai M, Karigane D, Nakajima H, Okamoto S, Hattori Y.
30th Annual Meeting of The Society for Immunotherapy of Cancer（SITC） (National Harbor, MD.) ,
2015.11,Poster presentation
-
Identification of New IMiDs-Binding Proteins and Nonteratogenic Drug Design for High-Risk Myeloma
ICHIKAWA DaijuMasashi Hozumi, Maiko Matsushita, Daiju Ichikawa, Yoshie Ozaki, Yuka Hasegawa, Fukiko Terada, Hiroshi Yanagawa, Noriko Tabata, Hirokazu Shiheido, Tukasa Oikawa, Koichi Matsuo, Taketo Yamada, Wenlin Du, Shotaro Kitabatake, Arimi Ueda, Yutaka Hattori
第77回日本血液学会学術集会,
2015.10,Oral presentation (general)
-
イマチニブ投与中止後CML患者におけるがん幹細胞抗原特異的CTLの解析
ICHIKAWA Daiju
第７回血液疾患免疫療法研究会学術集会,
2015.09,Poster presentation
-
ハイリスク多発性骨髄腫に対する新規治療薬の開発
ICHIKAWA Daiju
16回 Pharmaco-Hematologyシンポジウム（日本薬学会生物系薬学部会),
2015.06,Oral presentation (general)
-
白血病幹細胞に発現する新規がん精巣抗原の同定
ICHIKAWA Daiju
第 12回日本免疫治療学研究会学術集会,
2015.02,Oral presentation (general)
-
Development of a Novel Phthalimide Derivative, Preclinical Effects on High-risk Myeloma Cells and Osteoclasts.
Hattori Y, Matsushita M, Tabata N, Shiheido H, Yanagawa H, Hozumi M, Ueda A, Kitabatake S, Ichikawa D.
56th AMERICAN SOCIETY of HEMATOLOGY Annual Meeting and Exposition. (San Francisco, CA) ,
2014.12,Poster presentation
-
Clinical and biological significance of codon 72 polymorphism of TP53 gene in multiple myeloma.
Hozumi M, Ikeda Y, Suzuki Y, Matsushita M, Ichikawa D, Hattori Y.
第76回日本血液学会 (大阪) ,
2014.10,Oral presentation (general)
-
Identification of novel cancer-testis antigen expressed in leukemic stem cells of chronic myelogenous leukemia.
〇Matsushita M, Nakamura M, Ichikawa D, Tsukamoto N, Kawakami Y, Hattori Y.
43rd Annual Scientific Meeting of Society for Hematology and Stem Cells (Montreal, Canada) ,
2014.08 -
Codon 72 Polymorphism Of TP53 Gene Is a Novel Prognostic Marker For Thalidomide Therapy In Multiple Myeloma.
○Hattori Y, Ikeda Y, Suzuki Y, Ichikawa D, Matsushita M.
2013 Annual meeting of American Society of Hematology (New Orleans) ,
2013.12 -
Identification of novel cancer-testis antigen expressed in leukemic stem cells of chronic myelogenous leukemia.
Nakamura M, Matushita M, Ichikawa D, Tsukamoto N, Kawakami Y, Hattori Y.
第42回日本免疫学会総会 (幕張メッセ) ,
2013.12,Poster presentation
-
A myeloma cell line established from a patient refractory to thalidomide therapy.
○Ueda A, Matsunami S, Du W, Yamada T, Mori S, Ichikawa D, Matsushita M, Hattori Y.
第75回日本血液学会学術集会 (札幌) ,
2013.10 -
A myeloma cell line established from a patient refractory to thalidomide therapy.
Ueda A, Abe Y, Matsunami S, Du W, Yamada T, Shougo M, Ichikawa D, Matsushita M, Hattori Y.
第75回日本血液学会 (札幌教育文化会館) ,
2013.10,Oral presentation (general)
-
骨髄性白血病に対する免疫療法を目的としたHLA-A*2402拘束性PEPP2由来エピトープペプチドの同定.
○田中千晶, 大塚洋平, 松下麻衣子, 市川大樹, 油谷浩幸, 河上裕, 服部豊.
第72回日本癌学会学術総会 (横浜) ,
2013.10 -
Impact of novel agents to the additional-chromosomal abnormalities in patients with multiple myeloma.
○Hamano A, Abe Y, Miyazaki K, Sekine R, Tsukada N, Nakagawa Y, Kanno K, Hashimoto S, Ichikawa D, Matsushita M, Hattori Y, Suzuki K.
第75回日本血液学会学術集会 (札幌) ,
2013.10 -
サリドマイド治療抵抗性患者由来新規多発性骨髄腫細胞株の樹立と新規治療薬の開発.
○松浪早岐, 山田健人, 杜ぶん林, 柳川弘志, 市川大樹, 松下麻衣子, 服部豊.
第14回Pharmaco-Hematology Symposium (東京) ,
2013.06 -
Identification of Novel Cancer-testis Antigen Experssed in Leukemic Stem Cells of Chronic Myelogenous Leukemia.
○Matsushita M, Nakamura M, Tanaka C, Tsutsumida N, Suzuki T, Ichikawa D, Mori T, Matsuski E, Okamaoto S, Tsukamoto N, Kawakami Y, Hattori Y.
The 4th JSH International Symposium 2013 (Ehime) ,
2013.05